28 results on '"Su, Renyi"'
Search Results
2. mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma
3. Identification of a brand intratumor microbiome signature for predicting prognosis of hepatocellular carcinoma
4. Evaluation of liver regeneration after hemi-hepatectomy by combining computed tomography and post-operative liver function
5. Insulin-induced gene 2 protects against hepatic ischemia–reperfusion injury via metabolic remodeling
6. ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1
7. Human umbilical cord mesenchymal stem cells alleviate fatty liver ischemia‐reperfusion injury by activating autophagy through upregulation of IFNγ
8. E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation
9. An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
10. Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis
11. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
12. Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression.
13. ZIP4 inhibits Ephrin-B1 ubiquitination, activating Wnt5A/JNK/ZEB1 to promote liver cancer metastasis
14. Insulin-induced Gene 2 Protects against Hepatic Ischemia-reperfusion Injury via Metabolic Remodeling
15. Identification of a brand intratumor microbiome signature for predicting prognosis of hepatocellular carcinoma
16. Peritoneal Gene Transfection of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand for Tumor Surveillance and Prophylaxis.
17. An Inflammatory Liquid Fingerprint Predicting Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma
18. Systemic analysis identifying PVT1 / DUSP13 axis for microvascular invasion in hepatocellular carcinoma
19. Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level
20. Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in hepatocellular carcinoma.
21. CLIC1 Drives Angiogenesis in Hepatocellular Carcinoma by Modulating VEGFA
22. Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients
23. E2F7promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation
24. The ongoing trends of patient‐derived xenograft models in oncology
25. What Is the Role of Family History in Hepatocellular Carcinoma Development in a Han Chinese Population?
26. Impact of preoperative infection on the outcomes of liver transplant recipients: a national propensity score-matched retrospective cohort study in China.
27. Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.
28. Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.